Trial Profile
Phase II trial evaluating combined image guided radiotherapy with Panitumumab (Vectibix) in patients with muscle invasive transitional cell carcinoma of the bladder
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2015
Price :
$35
*
At a glance
- Drugs Panitumumab (Primary)
- Indications Bladder cancer
- Focus Adverse reactions
- 20 Jun 2011 New trial record